Human ERBB2 ELISA Kit

Introduction

The Human ERBB2 ELISA Kit is a cutting-edge tool used in the field of biomedical research for the detection and quantification of human epidermal growth factor receptor 2 (HER2), also known as ERBB2. This highly sensitive and specific assay provides valuable information about the structure, activity and potential therapeutic applications of this important biomarker.

Structure of ERBB2

ERBB2 is a transmembrane receptor protein that belongs to the epidermal growth factor receptor (EGFR) family. It is composed of 1255 amino acids and has a molecular weight of approximately 185 kDa. The protein consists of an extracellular domain, a transmembrane domain and an intracellular domain. The extracellular domain contains four different domains, including two ligand-binding domains, a cysteine-rich domain and a transmembrane domain. The intracellular domain has a tyrosine kinase activity that is crucial for the signaling function of ERBB2.

Activity of ERBB2

ERBB2 plays a critical role in the regulation of cell growth, proliferation and survival. It is activated by binding to specific ligands, such as epidermal growth factor (EGF) and transforming growth factor alpha (TGF-α), which leads to the formation of homo- or heterodimers with other members of the EGFR family. This dimerization triggers the tyrosine kinase activity of ERBB2, resulting in the activation of downstream signaling pathways, including the PI3K/AKT and MAPK/ERK pathways. These pathways are involved in various cellular processes, such as cell growth, differentiation, and survival.

Therapeutic Target

ERBB2 is overexpressed in a variety of human cancers, including breast, ovarian, gastric, and lung cancer. This overexpression is associated with poor prognosis and resistance to chemotherapy, making it an attractive therapeutic target. The Human ERBB2 ELISA Kit enables researchers to accurately measure the levels of ERBB2 in biological samples, providing valuable information for the development of targeted therapies. In fact, several FDA-approved drugs, such as trastuzumab and lapatinib, specifically target ERBB2 and have shown promising results in the treatment of ERBB2-positive cancers.

Research Use

The Human ERBB2 ELISA Kit has been widely used in various research studies to investigate the role of ERBB2 in different diseases and conditions. For instance, researchers have used this assay to measure the levels of ERBB2 in breast cancer patients and correlate it with tumor progression and response to therapy. Additionally, this kit has been utilized to study the role of ERBB2 in the development and progression of other cancers, such as gastric and lung cancer. Moreover, the Human ERBB2 ELISA Kit has been used in preclinical studies to evaluate the efficacy of novel ERBB2-targeted therapies.

Conclusion

In summary, the Human ERBB2 ELISA Kit is a powerful tool that provides valuable insights into the structure, activity, and potential therapeutic applications of ERBB2. Its high sensitivity and specificity make it an essential tool for researchers studying this important biomarker in various diseases and conditions. With the continued advancements in technology, this assay is expected to play an even more significant role in the future of biomedical research and the development of targeted therapies for ERBB2-positive cancers.